Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activitysort descending Investigator Unit Sponsor Date
A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Contract $91,617.50 Clinical Trial Pavani Chalasani Cancer Center Division Zeno Pharmaceuticals, Inc. 01/2020
A Phase 1, Open-label Study of ASP9801, an Oncolytic Virus, Administered by Intratumoral Injection in Patients with Advanced/Metastatic Solid Tumors Contract $458,027.74 Clinical Trial Hani Babiker Cancer Center Division Parexel International Corporation 01/2020
A Phase 2, Double-Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses.... Contract $273,767.50 Clinical Trial Cori Daines Asthma/Airway Disease Rsch Ctr Janssen Research & Development, LLC 01/2020
A Phase 2, Multi-Center, Open-Label Study to Evaluate Long-term Safety and Efficacy of CXA-10 in Subjects with Pulmonary Arterial Hypertension on Stable Background Therapy: Extension to Study CXA-10-3 Contract $80,418.76 Clinical Trial Franz Rischard Medicine Complexa, Inc. 01/2020
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS.. Contract $168,927.92 Clinical Trial Marilyn Glassberg Csete COM Phx Internal Medicine Kinevant Sciences, Inc. 08/2020
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate The Efficacy and Safety of Anamorelin HCL for the Treatment OF Malignancy Associated Weight Loss and Anorexia... Contract $42,626.00 Clinical Trial Charles Hsu Cancer Center Division PSI Pharma Support America, Incorporated 01/2020
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Contract $607,532.16 Clinical Trial Sachin Chaudhary Medicine Covance, Incorporated 08/2020
A Phase Ib/II Study of APG-115 in Combination with Pembrolizumab in Patients with Unresectable or Metastatic Melanomas or Advanced Solid Tumors Contract $513,891.00 Clinical Trial Montaser Shaheen Cancer Center Division Ascentage Pharma 01/2020
A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with... Contract $1,278,228.50 Clinical Trial Charles Hsu Radiation Oncology Astrazeneca 08/2020
A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors Contract $682,977.50 Clinical Trial Edward Gelmann Cancer Center Division Pharmacyclics Incorporated 04/2020
A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Naive Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel.. Contract $327,830.00 Clinical Trial Abhijeet Kumar Cancer Center Division Covance, Incorporated 01/2020
A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First- Line Treatment of BRCA Non-Mutated Advanced... Contract $100,897.00 Clinical Trial Setsuko Chambers Cancer Center Division GOG Foundation, Inc. 08/2020
Sleep SMART: Sleep for Stroke Management And Recovery Trial Cooperative Agreement $47,916.00 Clinical Trial Joyce Lee-Iannotti COM Phx Neurology University of Cincinnati 04/2020
Phase 3b Study for Evaluation of Efficacy and Nutritional Benefits of Pancrelipase in Patients with Exocrine Pancreatic Insufficiency due to Periampullary and Pancreatic Cancer Contract $122,409.40 Clinical Trial Hani Babiker Cancer Center Division AbbVie Incorporated 01/2020
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3819253 in Participants with Mild to Moderate COVID-19 Illness Contract $1,206,499.00 Clinical Trial Marilyn Glassberg Csete COM Phx Internal Medicine Eli Lilly and Company 08/2020
The MITRAL Trial (Mitral Implantation of TRAnscatheter VaLves is Native Mitral Stenosis) Contract $62,000.00 Clinical Trial Ashish Pershad COM Phx Internal Medicine Mayo Foundation for Medical Education and Research (Mayo Clinic) 01/2020
A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects With Mild or Moderate Coronavirus Disease (Covid Contract $503,260.68 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Pharmaceutical Research Associates 08/2020
COVID-19-C3PO: Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) Contract $1,222,500.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine University of Michigan 08/2020
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair with the Edwards PASCAL Transcatheter ...... Contract $141,792.00 Clinical Trial Ashish Pershad COM Phx Internal Medicine Edwards Lifesciences LLC 06/2020
CREON (Pancrelipase) Therapy for Subjects with Exocrine Pancreatic Insufficiency (EPI) due to Pancreatic Cancer: A Double-Blind, Randomized, Parallel Design with 2 Dose Cohorts of Pancrelipase... Contract $117,787.55 Clinical Trial Jen-Jung Pan COM Phx Internal Medicine AbbVie Incorporated 08/2020
(00007885) A Randomized, Double-Blind, Placebo-Controlled Study of 4-Hydroxytamoxifen Topic Gel Among Women with Mammograpically Dense Breast - (Fixed Price) Contract $78,600.00 Clinical Trial Pavani Chalasani Cancer Center Division University of Texas: MD Anderson Cancer Center 03/2020
A Phase 1 Study of ERK1/2 Inhibitor JSI-1187 Administered as Monotherapy and in Combination with Dabrafenib for the Treatment of Advanced Solid Tumors with MAPK Pathway Mutations Contract $643,931.75 Clinical Trial Hani Babiker Cancer Center Division Strategia Therapeutics 06/2020
Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms Contract $194,732.72 Clinical Trial Ashish Pershad COM Phx Internal Medicine BioVentrix, Inc. 08/2020
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 with Placebo and with Tofacitinib in Combination with Conventional Synthetic DMARDs.... Contract $314,050.00 Clinical Trial Chian Kwoh Arthritis Center-Research IQVIA RDS Inc. 03/2020
A Phase 1b/2 Study of AST-008 Combined with Pembrolizumab or Cemiplimab in Patients with Advanced Solid Tumors Contract $157,802.00 Clinical Trial Montaser Shaheen Cancer Center Division Exicure, Inc. 06/2020

Pages